Buda Juice, Inc. develops and distributes Ultra Fresh™ cold-crafted juices, lemonades and wellness shots for grocery retailers through an end-to-end refrigerated supply chain. Its news centers on retail distribution, branded product availability, white-label platform growth, financial results and public-company capital actions following its NYSE American listing under BUDA.
Company updates describe the Fresh35°™ or continuous 35°F cold chain, fresh perimeter placement in supermarkets, expansion beyond Texas into additional grocery markets and the role of clean-label citrus-based beverages as an alternative to shelf-stable drinks and in-store juicing.
Buda Juice (NYSE American: BUDA) reported full year fiscal 2025 results for the year ended December 31, 2025. Revenue increased 11.8% to $12.6M, gross profit rose 8.1% to $5.6M, operating income was $3.4M, net income was $3.5M, Adjusted EBITDA was $3.8M, and free cash flow was $3.0M.
The company completed an IPO in January 2026, which management says strengthened the balance sheet to support growth and Fresh35° cold-chain expansion.
Buda Juice (NYSE American: BUDA) will release fourth quarter and full year 2025 results and host a conference call and webcast on Thursday, March 26, 2026 at 11:30 a.m. ET.
According to the company, the earnings press release is expected prior to market open on March 26, 2026. A live webcast will be available on the investor relations site and a replay will be accessible through April 2, 2026 at 11:59 p.m. ET.
Buda Juice (NYSE American: BUDA) announced the underwriters fully exercised the 15% over-allotment in its initial public offering, adding 399,999 shares and bringing total shares sold to 3,066,666 at $7.50 per share for gross proceeds of approximately $23.0 million before fees. The offering has closed and BUDA began trading on January 8, 2026. The company said it is profitable and plans to use the capital to expand branded distribution, enter new markets and scale its white-label platform while marketing its UltraFresh™ cold-chain juice positioned in produce departments.
Buda Juice (NYSE American: BUDA) began regular-way trading on the NYSE American exchange on January 8, 2026 under the ticker BUDA. The company is described as a pioneer of the UltraFresh™ beverage category focused on cold-crafted citrus juices for supermarket fresh produce departments.
Buda Juice (NYSE:BUDA) priced an initial public offering of 2,666,667 shares at $7.50 per share, raising $20,000,000 of gross proceeds before underwriting discounts and offering expenses. The company granted the underwriter a 45-day option to purchase up to 400,000 additional shares (15%). Shares are expected to begin trading on NYSE American on January 8, 2026, and the offering is expected to close on January 9, 2026.
The company intends to use net proceeds to build production plants in South Carolina and Arizona/Nevada, expand Dallas capacity, support in-store marketing, and provide working capital. MDB Capital is the underwriter and the registration statement was declared effective on January 7, 2026.